483
AbbVie Inc.FDA 483 - AbbVie Inc. - June 18, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
AbbVie Inc. in North Chicago, IL, a sterile drug manufacturer, was cited for deficiencies in laboratory controls. The inspection revealed that the firm lacked scientifically sound justification for its Survanta stability testing program and failed to protect microbiology plates from desiccation during incubation. These issues indicate a failure to ensure the quality and purity of drug products and in-process materials.
Open in Dashboard
ID · 7e512946-7c93-4d23-9562-94c9c7dc0048